A comparative study of stabilising effect and antioxidant activity of different antioxidants on levodopa-loaded liposomes

References

• Angeles, D.C., et al., 2016. Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2. Annals of clinical and translational neurology, 3 (4), 288–294.
   PubMed Web of Science ®Google Scholar
• Antolovich, M., et al., 2002. Methods for testing antioxidant activity. The analyst, 127 (1), 183–198.
   PubMed Web of Science ®Google Scholar
• Berger, N., et al., 2001. Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics. International journal of pharmaceutics, 223 (1–2), 55–68.
   PubMed Web of Science ®Google Scholar
• Bors, W., Michel, C. and Schikora, S., 1995. Interaction of flavonoids with ascorbate acid determination of their univalent redox potentials. A pulse radiolysis study. Free radical biology and medicine, 19 (1), 45–52.
   PubMed Web of Science ®Google Scholar
• Buettner, G.R. and Jurkiewicz, B.A., 1996. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiation research, 145 (5), 532–541.
   PubMed Web of Science ®Google Scholar
• Butterfield, D.A. and Louderback, C.M., 2002. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free radical biology and medicine, 32 (11), 1050–1060.
   PubMed Web of Science ®Google Scholar
• Butterfield, D.A., Bader Lange, M.L. and Sultana, R., 2010. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochimica et biophysica acta, 1801 (8), 924–929.
   PubMed Web of Science ®Google Scholar
• Chen, C., et al., 2009. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein–Barr virus-transformed human B-cells. International journal of pharmaceutics, 366 (1–2), 133–139.
   PubMed Web of Science ®Google Scholar
• Choudhury, S.T., et al., 2016. Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride–mediated oxidative hepatocellular damage in rat model. International journal of nanomedicine, 11, 2179–2193.
   PubMed Web of Science ®Google Scholar
• Cortesi, R., et al., 2017. L-dopa co-drugs in nanostructured lipid carriers: a comparative study. Materials science and engineering C, materials for biological applications, 72, 168–176.
   PubMed Web of Science ®Google Scholar
• Davie, C.A., 2008. A review of Parkinson's disease. British medical bulletin, 86 (1), 109–127.
   PubMed Web of Science ®Google Scholar
• Di Stefano, A., et al., 2006. Maleic- and fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation. Journal of drug targeting, 14 (9), 652–661.
   PubMed Web of Science ®Google Scholar
• Dias, V., Junn, E. and Mouradian, M.M., 2013. The role of oxidative stress in Parkinson's disease. Journal of Parkinson's disease, 3 (4), 461–491.
   PubMedGoogle Scholar
• Diaz, N.L. and Waters, C.H., 2009. Current strategies in the treatment of Parkinson's disease and a personalized approach to management . Expert review of neurotherapeutics, 9 (12), 1781–1789.
   PubMed Web of Science ®Google Scholar
• Dua, J., Rana, A. and Bhandari, A., 2012. Liposomes: methods of preparation and applications. International journal of pharmaceutical research, 3 (2), 14–20.
   Google Scholar
• Esatbeyoglu, T., et al., 2012. Curcumin-from molecule to biological function. Angewandte chemie international edition, 51 (22), 5308–5332.
   PubMed Web of Science ®Google Scholar
• Fahn, S., 2008. The history of dopamine and Levodopa in the treatment of Parkinson's disease. Movement disorders, 23 (S3), S497–S508.
   PubMed Web of Science ®Google Scholar
• Goel, A., Kunnumakkara, A.B. and Aggarwal, B.B., 2008. Curcumin as “curcumin” from kitchen to clinic. Biochemical pharmacology, 75 (4), 787–809.
   PubMed Web of Science ®Google Scholar
• González-Rodríguez, M.L., et al., 2012. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery. Journal of pharmaceutical sciences, 101 (10), 3845–3863.
   PubMed Web of Science ®Google Scholar
• González-Rodríguez, M.L., et al., 2016. Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process. Drug development and industrial pharmacy, 42 (10), 1683–1694.
   PubMed Web of Science ®Google Scholar
• Hatcher, H., et al., 2008. Curcumin: from ancient medicine to current clinical trials. Cellular and molecular life sciences, 65 (11), 1631–1652.
   PubMed Web of Science ®Google Scholar
• Ihara, Y., et al., 1999. Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson’s disease: relationship to clinical data. Journal of the neurological sciences, 170 (2), 90–95.
   PubMed Web of Science ®Google Scholar
• Jiménez, D., Clavijo, Y. and Beltrán, D., 2014. Desnaturalización de proteínas. Thesis (PhD). Bogota University.
   Google Scholar
• Jin, H., et al., 2014. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochimica et biophysica acta, 1842 (8), 1282–1294.
   PubMed Web of Science ®Google Scholar
• Jovanovic, S.V., et al., 1999. H-atom transfer is a preferred antioxidant mechanism of curcumin. Journal of the American chemical society, 121 (41), 9677–9681.
   Web of Science ®Google Scholar
• Kankkunen, T., et al., 2002. Improved stability and release control of levodopa and metaraminol using ion-exchange fibers and transdermal iontophoresis. European journal of pharmaceutical sciences, 16 (4–5), 273–280.
   PubMed Web of Science ®Google Scholar
• Kibbe, A., 2009. Ascorbic acid. In: R.Rowe, P. Sheskey, and M. Quinn, eds. Handbook of pharmaceutical excipients. 6th ed. Great Britain: Pharmaceutical Press and American Pharmacists Association, 43–46.
   Google Scholar
• Kruk, I., et al., 1999. Formation of active oxygen species during autoxidation of dopa. Chemosphere, 39 (3), 443–453.
   Web of Science ®Google Scholar
• Kumar, K., et al., 2011. Stability of liposomes. Pharmanest, 2 (4), 0541–2231.
   Google Scholar
• Lesieur, S., et al., 1991. Size analysis and stability study of lipid vesicles by high-performance gel exclusion chromatography, turbidity and dynamic light scattering. Analytical biochemistry, 192 (2), 334–343.
   PubMed Web of Science ®Google Scholar
• Levy, O.A., Malagelada, C. and Greene, L.A., 2009. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis, 14 (4), 478–500.
   PubMed Web of Science ®Google Scholar
• Maestrelli, F., et al., 2006. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery. International journal of pharmaceutics, 312 (1–2), 53–60.
   PubMed Web of Science ®Google Scholar
• Maestrelli, F., et al., 2010. New “drug-in cyclodextrin-in deformable liposomes” formulations to improve the therapeutic efficacy of local anaesthetics. International journal of pharmaceutics, 395 (1–2), 222–231.
   PubMed Web of Science ®Google Scholar
• Manosroi, A., Podjanasoonthon, K. and Manosroi, J., 2002. Development of novel topical tranexamic acid liposome formulations. International journal of pharmaceutics, 235 (1–2), 61–70.
   PubMed Web of Science ®Google Scholar
• Manosroi, A., Kongkaneramit, L. and Manosroi, J., 2004. Characterization of amphotericin B liposome formulations. Drug development and industrial pharmacy, 30 (5), 535–543.
   PubMed Web of Science ®Google Scholar
• Mason, H.S. and Wricht, C.J., 1949. Chemistry of melanin. V. Oxidation of dihydroxyphenylalanine by tyrosinase. The journal of biological chemistry, 180 (1), 235–247.
   PubMed Web of Science ®Google Scholar
• Mikirova, N.A., Jackson, J.A. and Riordan, N.H., 2007. The effect of high dose IV vitamin C on plasma antioxidant capacity and level of oxidative stress in cancer patients and healthy subjects. Journal of orthomolecular medicine, 22 (3), 153–160.
   Google Scholar
• Nagai, T., et al., 2003. Preparation and antioxidant properties of water extract of propolis. Food chemistry, 80 (1), 29–33.
   Web of Science ®Google Scholar
• Nagayama, H., et al., 2004. The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clinical neuropharmacology, 27 (6), 270–273.
   PubMed Web of Science ®Google Scholar
• Paromov, V., et al., 2011. Protective effect of liposome encapsulated glutathione in a human epidermal model exposed to a mustard gas analog. Journal of toxicology, 2011, 1–11.
   Google Scholar
• Pavelic, Z., et al., 2005. Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. Journal of controlled release, 106 (1–2), 34–43.
   PubMed Web of Science ®Google Scholar
• Payton, F., Sandusky, P. and Alworth, W.L., 2007. NMR study of the solution structure of curcumin. Journal of natural products, 70 (2), 143–146.
   PubMed Web of Science ®Google Scholar
• Pisoschi, A.M. and Negulescu, G.P., 2011. Methods for total antioxidant activity determination: a review. Biochemistry & analytical biochemistry, 01 (01), 106.
   Google Scholar
• Rajan, R., et al., 2011. Transferosomes – a vesicular transdermal delivery system for enhanced drug permeation. Journal of advanced pharmaceutical technology and research, 2 (3), 138–143.
   PubMedGoogle Scholar
• Rengel, R., et al., 2002. High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. European journal of pharmaceutical sciences, 15 (5), 441–448.
   PubMed Web of Science ®Google Scholar
• Schneider, T., et al., 1996. Surface modification of continuously extruded contrast-carrying liposomes: effect on their physical properties. International journal of pharmaceutics, 132 (1–2), 9–21.
   Web of Science ®Google Scholar
• Smeyne, M. and Smeyne, R.J., 2013. Glutathione metabolism and Parkinson's disease. Free radical biology and medicine, 62, 13–25.
   PubMed Web of Science ®Google Scholar
• Spuch, C. and Navarro, C., 2011. Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer's disease and Parkinson's disease). Journal of drug delivery, 2011, 1.
   Google Scholar
• Thanvi, B.R. and Lo, T., 2004. Long term motor complications of levodopa: clinical features, mechanisms, and management strategies. Postgraduate medical journal, 80 (946), 452–458.
   PubMed Web of Science ®Google Scholar
• Umasuthan, N., et al., 2013. A manganese superoxide dismutase with potent antioxidant activity identified from Oplegnathus fasciatus: genomic structure and transcriptional characterization. Fish shellfish immunology, 34 (1), 23–37.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J., et al., 2014. Niosomes of ascorbic acid and α-tocopherol in the cerebral ischemia-reperfusion model in male rats. Biomed research international, 2014, 1.
   Web of Science ®Google Scholar
• Vieira, D.B. and Gamarra, L.F., 2016. Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. International journal of nanomedicine, 11, 538–5414.
   Web of Science ®Google Scholar
• Villasmil, S., et al., 2010. Positively and negatively charged liposomes as carriers for transdermal delivery of sumatriptan: in vitro characterization. Drug development and industrial pharmacy, 36 (6), 666–675.
   PubMed Web of Science ®Google Scholar
• Villasmil, S., Rabasco, A.M. and González-Rodríguez, M.L., 2013. Thermal and 31P NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. Comparative 31P NMR analysis on negatively and positively-charged liposomes. Colloids and surfaces B: biointerfaces, 105, 14–23.
   PubMed Web of Science ®Google Scholar
• Yadav, A. and Jain, D.K., 2011. Preparation and characterization of microparticulate system of propranolol hydrochloride. Journal of drug delivery and therapeutics, 1 (2), 15–20.
   Google Scholar
• Yang, T., et al., 2007. Liposome formulation of paclitaxel with enhanced solubility and stability. Drug delivery, 14 (5), 301–305.
   PubMed Web of Science ®Google Scholar
• Yang, H., et al., 2008. Preparation, characterization, and use of antioxidant-liposomes. Methods in molecular biology, 477 (1), 277–292.
   PubMedGoogle Scholar
• Zaitone, S.A., Hammad, L.N. and Farag, N.E., 2013. Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. Pharmaceutical reports, 65 (5), 1213–1226.
   PubMed Web of Science ®Google Scholar